Ovarian Tissue Current Events | Ovarian Tissue News | 2
|
| Page
2 of
32 |
636 Results |
|
|
|
Sort By:
Page Views | Date |
Healthcare professionals need training to help them talk more comfortably about sexual issues
Ovarian cancer affects sexual functioning, but healthcare professionals' knowledge about this is inadequate, as is their communication with patients about sexual issues, concludes a study in this week's BMJ. Interviews were conducted with 15 women with ovarian cancer and 43 clinicians and nurses in Leeds to determine their attitudes about, and... view more... (2001-10-09)
Oocyte-specific gene mutations cause premature ovarian failure
Mutations in a gene called FIGLA cause premature ovarian failure in at least a percentage of women who suffer from the disorder, said researchers from Baylor College of Medicine in Houston and Shandong University in China in a report that appears online today in the American Journal of Human Genetics. view more (2008-05-23)
Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene
Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations. view more (2008-01-02)
Low-fat diet possibly linked to lower risk of ovarian cancer
A low-fat diet may decrease the risk of ovarian cancer in postmenopausal women. view more (2007-10-10)
VEGF Trap shows activity in patients with advanced ovarian cancer
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents. view more (2007-06-04)
Promising new treatment option for women with recurrent ovarian cancer
Combining the new drug trabectedin with pegylated liposomal doxorubicin provides clinical benefit to women with relapsed ovarian cancer, according to new results presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm. view more (2008-09-16)
Gene therapy completely suppresses ovarian cancer growth in animal model
University of Pittsburgh School of Medicine researchers have used gene therapy to either completely abolish or significantly inhibit tumor progression in a mouse model of ovarian cancer. view more (2006-06-05)
Combination Chemotherapy Best Option For Treating Relapsed Ovarian Cancer (p 2099)
Results of a European study in this week's issue of THE LANCET suggest that combination treatment with paclitaxel and platinum-based chemotherapy could result in a modest but important survival benefit for women with relapsing ovarian cancer compared with women treated with platinum-based chemotherapy alone. Ovarian cancer is the fourth most... view more... (2003-06-19)
Obesity leads to more aggressive ovarian cancer, Cedars-Sinai research shows
Whether or not a woman is obese will likely affect her outcome once she has been diagnosed with ovarian cancer, according to a new study from Cedars-Sinai Medical Center. view more (2006-08-28)
First case of successful ovarian tissue transplantation between two, nonidentical sisters
A woman, whose ovaries had failed due to damage caused by chemotherapy and radiotherapy, has received a successful ovarian transplant from her genetically non-identical sister. view more (2007-08-02)
Multimarker assay for ovarian cancer most promising to date
The search for a specific protein that could help diagnose ovarian cancer in its early stages has for years eluded researchers who are seeking a reliable and accurate test for the disease. view more (2006-04-03)
PET/CT scan could be valuable noninvasive tool for determining stages of ovarian cancer
Combined positron emission tomography (PET) and computed tomography (CT) scanning of patients in the early stages of ovarian cancer can enable physicians to determine whether the cancer has spread to nearby lymph nodes without having to perform surgery. view more (2008-06-17)
Radical surgery best option for most ovarian cancer patients with cancer in diaphragm
In a retrospective study looking back at a decade of surgeries, Mayo Clinic Cancer Center researchers have determined that surgery to remove metastatic disease from the diaphragm, in conjunction with other procedures to remove the primary diseased tissue in ovarian cancer patients, significantly increases survival rates. view more (2005-10-13)
FDA approved leukemia drugs shows promise in ovarian cancer cells
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. view more (2009-11-10)
Scientists from University of Hawaii at Manoa find genetic marker
A new genetic marker associated with ovarian cancer risk was recently discovered by an international research group, led by scientists from the Cancer Research Genetic Epidemiology Unit in the United Kingdom. view more (2009-09-01)
Young early stage ovarian cancer patients can preserve fertility
A new study finds that young women with early-stage ovarian cancer can preserve future fertility by keeping at least one ovary or the uterus without increasing the risk of dying from the disease. view more (2009-08-10)
Researchers working on a better method of detecting ovarian cancer
According to the National Cancer Institute, ovarian cancer causes more deaths than any other cancer of the female reproductive system. An estimated 20,180 new cases of ovarian cancer are expected in the United States this year. view more (2006-04-04)
Tulane pioneers novel ovarian cancer treatment
The Tulane University Section of Hematology and Medical Oncology is investigating a novel treatment for ovarian cancer by using intravenous Ontak to deplete harmful cells that inhibit the body's natural immune response to fight cancer. Ovarian cancer is the fifth leading cancer killer of women in the United States. view more (2005-07-18)
HtrA1 and resistance to chemotherapy in ovarian and gastric cancers
While many cancer patients initially have a favorable response to chemotherapy for the treatment of solid tumors, resistance to treatment often develops. view more (2006-06-09)
EMSY: a new gene for breast/ovarian cancer
A new human breast and ovarian cancer gene has just been described by investigators in the last issue of the journal Cell. The gene, called EMSY, also characterises a subset of breast cancer with poorer survival, which makes it a potentially important diagnostic tool. view more (2003-12-10)
|
|
| Page
2 of
32 |
636 Results |
|
|
|
Sort By:
Page Views | Date |
|
